| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/04/2010 | EP1670744B1 4-((phenoxyalkyl)thio)-phenoxyacetic aci ds and analogs |
| 08/04/2010 | EP1670481B1 Use of ciclesonide for the treatment of inflammatory bowel diseases |
| 08/04/2010 | EP1667976B1 Isoquinolinone potassium channel inhibitors |
| 08/04/2010 | EP1638947B1 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1 |
| 08/04/2010 | EP1608344B1 Oral formulations of cladribine |
| 08/04/2010 | EP1497262B1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof |
| 08/04/2010 | EP1438015B1 Cosmetic and dermopharmaceutical compositions for skin prone to acne |
| 08/04/2010 | EP1429750B1 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 08/04/2010 | EP1343769B1 Benzoylpyridazines |
| 08/04/2010 | EP1100489B2 Method of altering nutritional components of milk produced by a lactating animal |
| 08/04/2010 | EP1045853B1 Synthesis of combretastatin a-4 prodrugs |
| 08/04/2010 | CN201536901U Neck pillow capable of placing auxiliary object |
| 08/04/2010 | CN1997360B Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether com |
| 08/04/2010 | CN1943637B Medicine for eliminating sputum and relieving asthma and its preparing method |
| 08/04/2010 | CN1934122B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 08/04/2010 | CN1915222B Composition of liposome, and preparation method |
| 08/04/2010 | CN1906302B Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS |
| 08/04/2010 | CN1882352B Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis |
| 08/04/2010 | CN1726911B Controlled release preparation of huperizine |
| 08/04/2010 | CN1717494B Beta-1,4-mannobiose-containing composition |
| 08/04/2010 | CN1360502B Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders |
| 08/04/2010 | CN101796188A SDF-1 binding nucleic acids and the use thereof |
| 08/04/2010 | CN101796187A Double-stranded RNA originating in lactic acid bacterium |
| 08/04/2010 | CN101796184A Compositions and methods of treating cancer |
| 08/04/2010 | CN101796056A heterocyclic inhibitors of c-met and uses thereof |
| 08/04/2010 | CN101796055A Inhibitors of VEGF receptor and HGF receptor signaling |
| 08/04/2010 | CN101796054A 1,4-diaza-bicycl0(3.2.2)n0nyl pyrimidinyl derivatives useful as nicotinic acetylcholine- receptor ligands |
| 08/04/2010 | CN101796053A Piperidine derivatives useful as orexin receptor antagonists |
| 08/04/2010 | CN101796052A Pyrrolopyridine derivatives and their use as BACE inhibitors |
| 08/04/2010 | CN101796048A Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 08/04/2010 | CN101796046A Pyrimidine derivatives 934 |
| 08/04/2010 | CN101796045A New chemical compounds |
| 08/04/2010 | CN101796043A Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators |
| 08/04/2010 | CN101796042A Novel compounds 951: a biphenyloxypropanoic acid as CRTH2 modulator and intermediates |
| 08/04/2010 | CN101796040A modulators of pharmacokinetic properties of therapeutics |
| 08/04/2010 | CN101796039A Phenylacetic acid compound |
| 08/04/2010 | CN101796036A 5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators |
| 08/04/2010 | CN101796034A Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 08/04/2010 | CN101796033A Substituted piperazines as CB1 antagonists |
| 08/04/2010 | CN101796032A Substituted piperazines as CB1 antagonists |
| 08/04/2010 | CN101796028A Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 08/04/2010 | CN101796024A Stereoisomers of tricyclodecan-9-yl-xanthogenate |
| 08/04/2010 | CN101796020A Novel triazine compounds for treatment of cancer |
| 08/04/2010 | CN101796018A (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament |
| 08/04/2010 | CN101796017A (carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament |
| 08/04/2010 | CN101795728A Isoxazole compound for the treatment of cancer |
| 08/04/2010 | CN101795727A Derivatives of 5-amino-4, 6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| 08/04/2010 | CN101795714A Method for promoting the expression of p53, and p53 expression promoter for use in the method |
| 08/04/2010 | CN101795710A Oral nicotine formulation buffered with amino acid |
| 08/04/2010 | CN101795704A Oral composition |
| 08/04/2010 | CN101795701A Inhibitors of acetyl-COA carboxylase for treatment of neuronal hypometabolism |
| 08/04/2010 | CN101795695A Self-assembling amphiphilic polymers as anticancer agents |
| 08/04/2010 | CN101795694A Injection, injection solution and injection kit preparation |
| 08/04/2010 | CN101795693A Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol |
| 08/04/2010 | CN101795692A Therapeutic substituted cyclopentanes for reducing intraocular pressure |
| 08/04/2010 | CN101795691A Salts of potassium atp channel openers and uses thereof |
| 08/04/2010 | CN101795690A Method for reducing intracranial pressure |
| 08/04/2010 | CN101795689A Benzamide mGluR5 positive allosteric modulators and methods of making and using same |
| 08/04/2010 | CN101795688A Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms |
| 08/04/2010 | CN101795687A A method for decreasing symptoms of alcohol consumption |
| 08/04/2010 | CN101795686A Dentifrice compositions for treating xerostomia |
| 08/04/2010 | CN101795685A hydroxyproline compositions and uses thereof |
| 08/04/2010 | CN101795684A Combinations of statins and anti-obesity agent |
| 08/04/2010 | CN101795683A Methods for promoting wakefulness |
| 08/04/2010 | CN101795682A Intravenous and oral dosing of a direct-acting and reversible P2Y12 inhibitor |
| 08/04/2010 | CN101795681A Method of preventing nephrocalcinosis |
| 08/04/2010 | CN101795680A excipients for protein stabilization |
| 08/04/2010 | CN101795679A 1-amino-alkylcyclohexane derivatives for the treatment of cochlear tinnitus |
| 08/04/2010 | CN101795678A Extracts with liver-X-receptor modulators, compounds and their use especially in weight control |
| 08/04/2010 | CN101795677A Spiro compounds for treatment of inflammatory disorders |
| 08/04/2010 | CN101795674A Tableted compositions containing atazanavir |
| 08/04/2010 | CN101795673A Enhanced formulations of lamotrigine |
| 08/04/2010 | CN101795672A Liposome formulations of boronic acid compounds |
| 08/04/2010 | CN101795671A Liposome compositions for in vivo administration of boronic acid compounds |
| 08/04/2010 | CN101795579A Protein free formula |
| 08/04/2010 | CN101795569A Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
| 08/04/2010 | CN101795568A Control of ectoparasites |
| 08/04/2010 | CN101795567A New heteocyclic H3 antagonists |
| 08/04/2010 | CN101795565A Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| 08/04/2010 | CN101795562A Animal parasite-control method using insect growth regulators |
| 08/04/2010 | CN101792788A Preparation method of 5'-acylated cytidine and application in preparing medicaments for treating heart and liver diseases |
| 08/04/2010 | CN101792783A Preparation method and application of banana natural resistant starch RS2 |
| 08/04/2010 | CN101792737A Culture method, application and combined preparation of hypoxia mesenchymal stem cell |
| 08/04/2010 | CN101792484A Anthracycline derivative of polypeptide containing tyrosine-isoleucine-glycine-serine-arginine |
| 08/04/2010 | CN101792483A Novel peptides as NS3-serine protease inhibitors of hepatitis c virus |
| 08/04/2010 | CN101792477A Acetyl ursolic acid acylate triethanolamine monoester with anti-cancer activity and preparation method thereof |
| 08/04/2010 | CN101792475A CDP-2-glycerol synthesized in gram-positive bacteria and preparation method thereof |
| 08/04/2010 | CN101792474A Novel AzalomycinF microlide compounds and preparation method thereof and application thereof |
| 08/04/2010 | CN101792473A Novel ketolide compound and preparation method and application thereof |
| 08/04/2010 | CN101792450A spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 08/04/2010 | CN101792449A Raubasine derivative, preparation and application thereof |
| 08/04/2010 | CN101792448A Nacyline derivative, preparation and application |
| 08/04/2010 | CN101792444A Sodium levofolinate and preparation method and drug combination thereof |
| 08/04/2010 | CN101792443A Fluoro-carbostyril derivative as well as preparation method and application thereof |
| 08/04/2010 | CN101792441A Crystal forms of palonosetron hydrochloride and preparation method thereof |
| 08/04/2010 | CN101792440A Quinazolinone derivatives, preparation and application thereof |
| 08/04/2010 | CN101792437A Tolyltriazole derivatives, preparation method thereof and use thereof |
| 08/04/2010 | CN101792436A Benzimidazole derivatives used in the treatment of diseases associated with vanilloid receptor 1 |
| 08/04/2010 | CN101792418A Geldanamycin biosynthetic analog 19-O-glycyl geldana |
| 08/04/2010 | CN101792417A Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |